138 related articles for article (PubMed ID: 21888924)
1. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
[TBL] [Abstract][Full Text] [Related]
2. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
3. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
4. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
5. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.
Chiang KC; Yeh CN; Hsu JT; Yeh TS; Jan YY; Wu CT; Chen HY; Jwo SC; Takano M; Kittaka A; Juang HH; Chen TC
Cell Cycle; 2013 Apr; 12(8):1316-25. PubMed ID: 23549173
[TBL] [Abstract][Full Text] [Related]
7. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
8. Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
Iglesias-Gato D; Zheng S; Flanagan JN; Jiang L; Kittaka A; Sakaki T; Yamamoto K; Itoh T; Lebrasseur NK; Norstedt G; Chen TC
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):269-75. PubMed ID: 21911059
[TBL] [Abstract][Full Text] [Related]
9. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
Chiang KC; Kuo SF; Chen CH; Ng S; Lin SF; Yeh CN; Chen LW; Takano M; Chen TC; Juang HH; Kittaka A; Lin JD; Pang JH
Cancer Lett; 2015 Dec; 369(1):76-85. PubMed ID: 26282787
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
Campbell MJ; Reddy GS; Koeffler HP
J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
[TBL] [Abstract][Full Text] [Related]
13. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
[TBL] [Abstract][Full Text] [Related]
14. 19-Norvitamin D analogs for breast cancer therapy.
Matsumoto Y; Kittaka A; Chen TC
Can J Physiol Pharmacol; 2015 May; 93(5):333-48. PubMed ID: 25918960
[TBL] [Abstract][Full Text] [Related]
15. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
Chiang KC; Yeh CN; Pang JH; Hsu JT; Yeh TS; Chen LW; Kuo SF; Hsieh PJ; Pan YC; Takano M; Chen TC; Feng TH; Kittaka A; Juang HH
Anticancer Res; 2016 Jul; 36(7):3307-13. PubMed ID: 27354587
[TBL] [Abstract][Full Text] [Related]
16. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
Chiang KC; Yeh TS; Chen SC; Pang JH; Yeh CN; Hsu JT; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Sun CC; Juang HH
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110769
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.
Kittaka A; Hara H; Takano M; Sawada D; Arai MA; Takagi K; Chida T; Harada Y; Saito H; Takenouchi K; Ishizuka S; Hayashi K; Ikushiro S; Sakaki T; Sugiura T; Chen TC
Anticancer Res; 2009 Sep; 29(9):3563-9. PubMed ID: 19667149
[TBL] [Abstract][Full Text] [Related]
19. Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells.
Chiang KC; Persons KS; Istfan NW; Holick MF; Chen TC
Anticancer Res; 2009 Sep; 29(9):3591-6. PubMed ID: 19667153
[TBL] [Abstract][Full Text] [Related]
20. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
